Metraipolis › archive › dc_d1c55bf04b60

Safety and Efficacy of the Novel OmniaSecure Defibrillation Lead Through Long-Term Follow-Up: Final Results From the LEADR Trial — Europe PMC PMID:41222500

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41222500
DOI
10.1161/circep.125.014424
License (as archived)
solo-consultazione
Archived
2026-10-07T11:32:14.373Z
SHA-256 of the archived text
75f1fdf46e91c616be2ddf36b0679098ace5e7bff22fc349f06985cff8ef1ff3
Stable URL of this page
https://metraipolis.com/documento/dc_d1c55bf04b60

How to cite

Safety and Efficacy of the Novel OmniaSecure Defibrillation Lead Through Long-Term Follow-Up: Final Results From the LEADR Trial — Europe PMC PMID:41222500 — Europe PMC (en), https://europepmc.org/article/MED/41222500 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d1c55bf04b60 (Metraipolis archive dc_d1c55bf04b60, sha256 75f1fdf46e91c616be2ddf36b0679098ace5e7bff22fc349f06985cff8ef1ff3)
BibTeX
@misc{dcd1c55bf04b60,
  title = {Safety and Efficacy of the Novel OmniaSecure Defibrillation Lead Through Long-Term Follow-Up: Final Results From the LEADR Trial — Europe PMC PMID:41222500},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41222500},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d1c55bf04b60; sha256 75f1fdf46e91c616be2ddf36b0679098ace5e7bff22fc349f06985cff8ef1ff3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41222500. Agents can read the archived copy with the MCP tool read_document.